The deal is fully priced at $95/share and requires majority of outstanding shares to approve. If approved, ATKR stockholders will receive cash and shares will be delisted. Monitor the October 7 vote and regulatory developments (HSR, Austria, Australia, Canada). The spread between current price (~$93.87) and $95.00 suggests minimal arbitrage opportunity and high market expectation of close. Any regulatory challenge or voting shortfall would create downside risk.
Price Chart
Executive Summary
Atkore Inc. filed a definitive proxy statement (DEFM14A) for a special meeting on October 7, 2026 to seek stockholder approval of its acquisition by Prysmian S.p.A. for $95.00 per share in cash, a ~30% premium to the undisturbed price of $72.96. The Board unanimously recommends a FOR vote, and both financial advisors (Citi and J.P. Morgan) opined that the consideration is fair from a financial point of view.
Key Financial Metrics
Key Facts
- Merger Consideration: $95.00 per share in cash, representing ~30% premium to July 31, 2026 closing price of $72.96 and ~57% premium to September 29, 2025 closing price of $60.69
- Board unanimously approved and recommends stockholders vote FOR the Merger Proposal
- Citi and J.P. Morgan each rendered fairness opinions to the Board
- Special Meeting: October 7, 2026, virtual-only; record date September 4, 2026
- Required vote: affirmative vote of holders of a majority of outstanding shares (33,773,062 shares outstanding as of record date)
- Termination fee payable by Atkore: $115,920,000 under specified circumstances
- HSR waiting period filed August 14, 2026, expected to expire September 14, 2026
- Targeted closing by calendar year end 2026, subject to stockholder approval, HSR clearance, and approvals from Austria, Australia and Canada
- Directors and executive officers beneficially own ~0.7% of shares and intend to vote FOR
- Appraisal rights available under Delaware law
Financial Impact
All outstanding shares of ATKR common stock will be cancelled and converted into the right to receive $95.00 per share in cash, totaling approximately $3.21 billion based on 33.8 million shares outstanding; termination fee of $115.92 million if deal fails under certain conditions
Risk Factors
- Failure to obtain stockholder approval (majority of outstanding shares required; abstentions count as against)
- Regulatory delays or challenges from HSR review or foreign antitrust authorities (Austria, Australia, Canada)
- Potential competing bid or termination of Merger Agreement triggering $115.92M termination fee
- Adverse economic or market conditions prior to closing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFM14A Filing (Primary) | 0001140361-26-035981 |
| Document: ny20080616x2_defm14a.htm | 0001140361-26-035981 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | DEFA14A / 8-K | $94.55 $94.32 | ▼ −0.24% | ▼ −1.06% | $94.77 (+0.23%) |
Sep 9, 2026 23d ago | DEFM14A | $94.21 $94.52 | ▲ +0.33% | ▲ +1.42% | $94.77 (+0.59%) |
Aug 28, 2026 5w ago | PREM14A | $93.60 $93.76 | ▲ +0.17% | ▲ +0.06% | $94.77 (+1.25%) |
Aug 26, 2026 5w ago | Institutional Cluster | $93.63 $93.55 | ▼ −0.09% | ▲ +0.03% | $94.77 (+1.22%) |
Aug 3, 2026 8w ago | DEFA14A | $93.53 $93.87 | ▲ +0.36% | ▲ +0.46% | $94.77 (+1.33%) |
Aug 3, 2026 8w ago | DEFA14A | $93.55 $93.75 | ▲ +0.21% | ▼ −1.81% | $94.77 (+1.30%) |
Apr 8, 2026 25w ago | 8-K | $65.91 $67.68 | ▲ +2.69% | ▼ −0.83% | $94.77 (+43.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access